Vicapsys Life Sciences, Inc. is a Florida-incorporated biopharmaceutical holding company developing encapsulated product candidates incorporating proprietary derivatives of the chemokine CXCL12 to create immunoprotection zones around cells, tissues, organs, and devices. Its lead product line VICAPSYN targets transplantation therapies including Type 1 Diabetes treatment via encapsulated human islet cell clusters. A second line, VYBRIN, addresses anti-fibrotic applications including post-surgical adhesion prevention, implantable device coating, and diabetic wound healing.
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2024-10-21 | 2023-12-31 | 0001493152-24-041809 | EDGAR | 45K words |
| 2023-04-14 | 2022-12-31 | 0001493152-23-012267 | EDGAR | — |
| 2022-03-16 | 2021-12-31 | 0001493152-22-006994 | EDGAR | — |
| 2021-09-17 | 2020-12-31 | 0001493152-21-022984 | EDGAR | — |
| 2010-05-24 | 2009-12-31 | 0001144204-10-029858 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-01-10 | 2024-09-30 | 0001493152-25-001779 | EDGAR | 16K words |
| 2025-01-10 | 2024-06-30 | 0001493152-25-001776 | EDGAR | — |
| 2025-01-10 | 2024-03-31 | 0001493152-25-001743 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-040951 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028151 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017138 | EDGAR | — |
| 2022-11-21 | 2022-09-30 | 0001493152-22-033024 | EDGAR | — |
| 2022-08-16 | 2022-06-30 | 0001493152-22-023207 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001493152-22-013375 | EDGAR | — |
| 2021-11-12 | 2021-09-30 | 0001493152-21-027976 | EDGAR | — |
| 2021-09-20 | 2021-06-30 | 0001493152-21-023189 | EDGAR | — |
| 2021-09-20 | 2021-03-31 | 0001493152-21-023170 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2023-12-27 | 0001493152-23-046217 | EDGAR | 1K words |
| 2023-06-30 | 0001493152-23-023183 | EDGAR | — |
| 2023-06-02 | 0001493152-23-019905 | EDGAR | — |
| 2023-05-17 | 0001493152-23-017970 | EDGAR | — |
| 2023-01-12 | 0001493152-23-001296 | EDGAR | — |
| 2022-09-28 | 0001493152-22-027017 | EDGAR | — |
| 2022-04-12 | 0001493152-22-009690 | EDGAR | — |
| 2010-07-01 | 0001144204-10-036040 | EDGAR | — |
| 2010-05-18 | 0001144204-10-028744 | EDGAR | — |
| 2010-04-26 | 0001144204-10-022071 | EDGAR | — |
41 total filings indexed. 14 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001468639 |
| Ticker | VICP |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | FL |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VICP (~200 tokens, structured JSON with cryptographic provenance)